Hemorrhagic cystitis in the critically ill cancer patient

Chukwuma O. Kalu; Ala Abudayyeh

doi:10.1007/978-3-319-74588-6_77

Hemorrhagic cystitis in the critically ill cancer patient

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Cancer patients are at increased risk for cystitis due to primary bladder cancer, metastatic disease, infectious etiology due to immunosuppression, or chemical induced due to antineoplastic treatments or radiation induced. Patients at increased risk are ones receiving high dose chemotherapies such as stem cell transplant recipients. We will present urological complications in cancer patients with the associated risk factors, preventative measures, treatments, and outcomes. Morbidity and mortality associated with cancer treatments is further escalated when hemorrhagic cystitis ensues.

Original language	English (US)
Title of host publication	Oncologic Critical Care
Publisher	Springer International Publishing
Pages	959-968
Number of pages	10
ISBN (Electronic)	9783319745886
ISBN (Print)	9783319745879
DOIs	https://doi.org/10.1007/978-3-319-74588-6_77
State	Published - Oct 12 2019

Keywords

Allogeneic transplantation
BK virus
Bladder dysfunction
Hematopoietic cell transplantation
Hemorrhagic cystitis
Hyperbaric oxygen
Platelet engraftment
Quality of life
Stem cell transplantation

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-74588-6_77

Cite this

@inbook{bbba4d28f20b4688afefc6e4c5848026,

title = "Hemorrhagic cystitis in the critically ill cancer patient",

abstract = "Cancer patients are at increased risk for cystitis due to primary bladder cancer, metastatic disease, infectious etiology due to immunosuppression, or chemical induced due to antineoplastic treatments or radiation induced. Patients at increased risk are ones receiving high dose chemotherapies such as stem cell transplant recipients. We will present urological complications in cancer patients with the associated risk factors, preventative measures, treatments, and outcomes. Morbidity and mortality associated with cancer treatments is further escalated when hemorrhagic cystitis ensues.",

keywords = "Allogeneic transplantation, BK virus, Bladder dysfunction, Hematopoietic cell transplantation, Hemorrhagic cystitis, Hyperbaric oxygen, Platelet engraftment, Quality of life, Stem cell transplantation",

author = "Kalu, {Chukwuma O.} and Ala Abudayyeh",

year = "2019",

month = oct,

day = "12",

doi = "10.1007/978-3-319-74588-6_77",

language = "English (US)",

isbn = "9783319745879",

pages = "959--968",

booktitle = "Oncologic Critical Care",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Hemorrhagic cystitis in the critically ill cancer patient

AU - Kalu, Chukwuma O.

AU - Abudayyeh, Ala

PY - 2019/10/12

Y1 - 2019/10/12

N2 - Cancer patients are at increased risk for cystitis due to primary bladder cancer, metastatic disease, infectious etiology due to immunosuppression, or chemical induced due to antineoplastic treatments or radiation induced. Patients at increased risk are ones receiving high dose chemotherapies such as stem cell transplant recipients. We will present urological complications in cancer patients with the associated risk factors, preventative measures, treatments, and outcomes. Morbidity and mortality associated with cancer treatments is further escalated when hemorrhagic cystitis ensues.

AB - Cancer patients are at increased risk for cystitis due to primary bladder cancer, metastatic disease, infectious etiology due to immunosuppression, or chemical induced due to antineoplastic treatments or radiation induced. Patients at increased risk are ones receiving high dose chemotherapies such as stem cell transplant recipients. We will present urological complications in cancer patients with the associated risk factors, preventative measures, treatments, and outcomes. Morbidity and mortality associated with cancer treatments is further escalated when hemorrhagic cystitis ensues.

KW - Allogeneic transplantation

KW - BK virus

KW - Bladder dysfunction

KW - Hematopoietic cell transplantation

KW - Hemorrhagic cystitis

KW - Hyperbaric oxygen

KW - Platelet engraftment

KW - Quality of life

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=85086496057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086496057&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-74588-6_77

DO - 10.1007/978-3-319-74588-6_77

M3 - Chapter

AN - SCOPUS:85086496057

SN - 9783319745879

SP - 959

EP - 968

BT - Oncologic Critical Care

PB - Springer International Publishing

ER -

Hemorrhagic cystitis in the critically ill cancer patient

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this